Effect of Pharmaceutical Intervention on Rational Rate of Antibacterial Drug Use in Medical Insurance Under DIP Payment Mode Reform
Objective To explore how to rationally use antimicrobials under the gradual promotion and popularization of diagnos-intervention packet(DIP)payment method,so as to provide references for clinical pharmacists to promote rational use of antimicrobials in clinic and fine control of antimicrobials in medical insurance.Methods Patients hospitalized in the gastroenterology department of the Second Affiliated Hospital of Baotou Medical College,Inner Mongolia University of Science and Technology were selected as the study target.6 752 patients from January to December 2020 were selected as the control group,and 6 562 patients from January to December 2021 were selected as the observation group.The per capita cost of antibiotics,the proportion of the amount of antibiotics,the per capita number of days in hospital,the utilization rate and intensity of antibiotics,and the rate of pathogenic microorganisms submitted before the use of antibiotics(hereinafter referred to as the rate of submission)were compared between the two groups,and whether the restricted varieties of antibiotics under medical insurance were reasonable was monitored.Results The per capita cost of antibiotics,the proportion of antibiotics money,the utilization rate of antibiotics and the rate of examination in the observation group were significantly better than those in the control group(P＜0.05).There was no significant difference in the average days of antibiotic use between the two groups(P＞0.05).The medical insurance rationality rate of other key monitoring antibiotics except cefoxitin in observation group was significantly higher than that in control group(P＜0.05).Conclusion Clinical pharmacists use their professional skills,through pre-intervention,communication in the process and follow-up feedback,etc.,successfully reduce the cost of medical insurance antibacterial drugs in medical institutions,improve the bacterial detection rate of antibacterial drugs,slow down the use of antibacterial drugs,and improve the correct application of medical insurance restricted drugs.
pay fees according to the value of the diseaseclinical pharmacistintervention measureshealth insuranceantimicrobial drugsfair use
万方数据
维普
